APOC3 and coronary artery disorder: This resulted in an HDL-ApoCIII/VLDL-ApoCIII ratio that was significantly higher in CAD patients than in non-CAD subjects in all groups (P=0.002–0.0001; Table 3), with the lowest ratio value in CAD patients being 3.6 and the lowest ratio value in non-CAD subjects being 1.8 (Table 3).